HORIZON-JU-GH-EDCTP3-2024-Mpox
HORIZON-JU-GH-EDCTP3-2024-Mpox
Programme: Horizon Europe
9 projects · €12,103,329 total EU contribution (project-level) · 43 participating organizations · 24 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€12,103,329
Countries active
Participant organizations by country (headquarters in CORDIS).
- UK (5)
- BE (4)
- CD (3)
- Spain (3)
- UG (3)
- CA (2)
- CG (2)
- France (2)
- Italy (2)
- RW (2)
- TZ (2)
- BF (1)
- BI (1)
- CH (1)
- Germany (1)
- DK (1)
- FI (1)
- IE (1)
- KE (1)
- Netherlands (1)
- NO (1)
- SE (1)
- US (1)
- ZA (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- UCB5 projects · CD
- INRB3 projects · CD
- UNIKIN3 projects · CD
- MAKERERE UNIVERSITY LUNG INSTITUTE2 projects · UG
- NIMR2 projects · TZ
- UNHRO2 projects · UG
- UANTWERPEN2 projects · BE
- ACE Research1 projects · KE
- CSIC1 projects · ES
- CENTRE NATIONAL DE RECHERCHE SCIENTIFIQUE ET TECHNOLOGIQUE*INSTITUT DE RECHERCHE EN SCIENCES DE LA SANTE1 projects · BF
- TECHNICAL UNIVERSITY OF DENMARK DTU1 projects · DK
- ERASMUS MC1 projects · NL
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Implementing wastewater and environmental surveillance for Mpox in Sub-Saharan Africa ODIN-MPox · 101195186 | HORIZON | €1,378,273 | €294,189 | Details |
Addressing Critical Gaps in mpox epidemiology in DRC - The MOVIE and TRACE studies MOVIE-TRACE · 101195270 | HORIZON | €1,430,875 | €70,400 | Details |
MATERNAL AND INFANT SAFETY AND IMMUNOGENICITY IN A PHASE 3, OPEN-LABEL, RANDOMISED, VACCINE TRIAL OF A TWO-DOSE MPOX VACCINE PregInPoxVac · 101195533 | HORIZON | €1,599,328 | €98,000 | Details |
Tackling and investigating the South-Kivu mpox outbreak MBOTE-SK · 101195465 | HORIZON | €1,263,076 | €250,475 | Details |
Strengthening epidemiological, genomic and community surveillance of Mpox virus (MPXV) at the Congo River border for DRC and RoC MPOX-PROBE · 101195102 | HORIZON | €1,299,994 | €484,243 | Details |
Joint Understanding and Analysis of clade I monkeypox epidemiology, evolution and immunology in South Kivu JUA KIVU · 101195116 | HORIZON | €1,250,000 | €145,000 | Details |
Deciphering host genetics and viral determinants of MPOX epidemiology in the Democratic Republic of Congo DECIPHER-MPOX · 101194676 | HORIZON | €1,260,000 | €224,750 | Details |
Impact of MPXV infection on pregnancy outcome and newborn health PREGMPOX · 101195146 | HORIZON | €1,250,000 | €639,391 | Details |
Expanding a prospective, clinical trial examining the immune response of participants receiving Modified Vaccinia Ankara vaccine to Africa. MpoxVax AFRIVAC · 101195540 | HORIZON | €1,371,784 | €215,949 | Details |